Snippets: CeNeS in offer talks; Celsis sees strong trading

AIM-listed CeNeS Pharmaceuticals plc said it is in discussions with unnamed parties that may or may not lead to an offer for the Company.

The ten year old Cambridge-based biotech specialising in the central nervous system drug market has a market capitalisation of around £12.75m

+ + + +

Celsis International plc, the life sciences products and laboratory services company, said it has continued to see strong trading into the second half of the financial year to end December following its positive interim results.

It said excellent performances have been seen from the Rapid Detection and In Vitro Technologies divisions, particularly during December, and the Group overall continues to trade in line with the Board's expectations.

CEO Jay LeCoque (pictured) said: "Celsis is well positioned to grow organically, with progress in the Rapid Detection and In Vitro Technologies divisions being particularly encouraging during the quarter.

“In addition, we continue to review new acquisition opportunities. Overall, the Company looks forward to a positive year end performance, with revenue and profit growth in line with the Board's expectations."

+ + + +

Autonomy ZANTAZ, specilaist in the archiving, eDiscovery and policy management markets, announced its unique ability to discover electronically stored information (ESI) in all virtual environments, including those powered by VMWare, further extending its lead in eDiscovery.

In order for companies to be compliant with the Federal Rules of Civil Procedure (FRCP), eDiscovery software must be able to find and hold all information relevant to litigation, including more complex file types such as virtual images, multimedia attachments, voice, video, IM and blackberry messages.

According to VMWare, all Fortune 100 and 20,000 corporate customers benefit from substantially lower IT costs, choice of operating systems, and a more automated and resilient systems infrastructure delivered by VMWare. When it comes to performing eDiscovery, these virtual environments are being overlooked due to complexities associated with the mapping, auditing and reporting duties under FRCP since an organization must be able to identify where the information is stored.

7th February 2008


Previous articles
Medical Solutions to buy Geneservice for £3.86m, move it to Nottingham
Tough year on the stock market for Silicon Fen's Top Ten but Autonomy sparkles
Meldex launches a division in Germany; reports strong organic growth
Aveva powers ahead as 05/06 trading, profits beat expectations
CSR’s 1Q08 revenues flat; short term prognosis disappoints market, share price sheds 20%
Cambridge Consultants’ Bluetooth tool cuts size, cost of headset for hard-of-hearing
News briefs: ARM expands in India; Amino signs Caribbean deal
Fulton buys Splashpower out of liquidation
Stem Cell Sciences relocates commercial ops, head office to Cambridge
18 up and comers from around Cambridge make ‘Gauntlet’ shortlist
Subscribe

 

Corporate profiles

 • Plasmon


Rod Powell PSc, CEng, FCMA
Non-executive Chairman


Founded in 1984, Plasmon is a pioneer in optical storage technology and has emerged as a leader in the archival storage industry. Plasmon develops and manufactures UDO (Ultra Density Optical) professional 5.25 inch optical drives and media, designed to meet the secure archival storage demands of corporations

[Plasmon's profile]


Top20 Index




Currently: 71.78


Create Publisher Site
This Publisher Website ( slot3.siliconfenbusiness.com ) does not exist in Direct-Link-Ads.com. Please create it now.